Aradhana M Venkatesan

Aradhana M Venkatesan is a Senior Professor at The University of Texas MD Anderson Cancer Center, where she specializes in oncologic imaging. Her research focuses on advanced MRI techniques for prostate and gynecologic cancers, including brachytherapy planning, as well as the radiologic assessment of renal cell carcinoma subtypes. She has recently published on integrating MRI with the 2023 FIGO staging system for endometrial cancer, fertility preservation imaging in female oncology patients, and remote MRI scanning support to expand radiology access. Her work includes contributions to the STARLITE 1 trial, evaluating 177Lu-girentuximab combined with cabozantinib and nivolumab in advanced clear-cell renal cell carcinoma. She is actively involved in updating international guidelines, including the ESUR recommendations for endometrial cancer imaging.